腭扁桃体结石与放线菌:成人扁桃体切除术的多机构研究
该双机构回顾性病例对照研究纳入134例成人扁桃体切除术患者,比较扁桃体结石与无结石标本中放线菌的检出率。结果显示,结石标本复评后放线菌检出率高达95%,但非结石标本中放线菌也常见,提示放线菌可能不是扁桃体结石形成的主要驱动因素。
要点
- 扁桃体结石标本复评后放线菌检出率95%,但非结石标本也常见。
- 放线菌在结石与非结石标本中均高发,可能不是结石主要病因。
- 针对放线菌的靶向治疗对扁桃体结石可能无效。
核心结论
- 扁桃体结石标本中放线菌检出率很高,但放线菌也常规定植于非结石扁桃体标本,因此放线菌不太可能是扁桃体结石发病的主要驱动因素,针对放线菌的治疗可能无效。
研究设计与样本
- 双机构回顾性病例对照研究,纳入2006年1月至2018年12月接受扁桃体切除术的成人患者。
- 研究人群共134例,包括扁桃体结石62例,非结石对照72例(扁桃体肥大30例、慢性扁桃体炎30例、同侧口咽癌患者对侧外观正常扁桃体12例)。
主要发现
- 初始病理报告中放线菌在扁桃体结石患者中报告率为11%,复评后为95%(57例中54例)。
- 扁桃体结石患者放线菌阳性率显著高于复发性扁桃体炎患者(73%,30例中22例,P < .001)。
- 扁桃体结石患者放线菌阳性率显著高于同侧口咽癌患者对侧外观正常扁桃体(58%,12例中7例,P < .001)。
- 扁桃体结石患者与扁桃体肥大患者放线菌阳性率差异无统计学意义(83%,30例中25例,P = .11)。
临床怎么用
- 临床遇到扁桃体结石时,不应仅基于放线菌检出而常规使用针对放线菌的靶向治疗。
- 扁桃体结石的治疗策略需进一步研究,当前证据不支持将放线菌作为主要治疗靶点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To better characterize associations between Actinomyces and tonsillolith versus nontonsillolith tonsillectomy specimens. STUDY DESIGN: Bi-institutional retrospective case-case study. SETTING: University and county hospital. SUBJECTS AND METHODS: Adult patients with a clinical history of tonsilloliths who underwent tonsillectomy from January 2006 to December 2018 were included. Patients undergoing tonsillectomy for tonsillar hypertrophy and chronic tonsillitis were identified as comparative cases. Similarly, patients with ipsilateral oropharyngeal cancer (OPC) who underwent contralateral tonsillectomy of a normal-appearing tonsil for prophylaxis against a second primary cancer were also included as comparative cases. RESULTS: The study population comprised 134 patients who underwent tonsillectomy: 62 tonsillolith and 72 nontonsillolith (tonsillar hypertrophy, n = 30; chronic tonsillitis, n = 30; normal-appearing contralateral tonsil in patients with ipsilateral OPC, n = 12). Actinomyces was reported in 11% of the patients with tonsilloliths on initial pathology reports but in 95% after re-evaluation (n = 54 of 57). Actinomyces prevalence was significantly higher in patients with tonsilloliths as compared with patients with recurrent tonsillitis (73%, n = 22 of 30, P < .001) and normal-appearing contralateral tonsils in patients with ipsilateral OPC (58%, n = 7 of 12, P < .001). Actinomyces prevalence was not significantly different between patients with tonsilloliths and tonsillar hypertrophy (83%, n = 25 of 30, P = .11). CONCLUSION: The prevalence of Actinomyces in tonsillolith tonsil specimens is high; however, Actinomyces routinely colonizes nontonsillolith tonsil specimens. Therefore, Actinomyces is unlikely to be the primary driver of tonsillolith pathogenesis, and Actinomyces-targeted treatment of tonsilloliths may not be effective. Treatment strategies addressing tonsilloliths should be further investigated.
引用
- Arvisais-Anhalt S, Quinn A, Bishop JA, et al. Palatine Tonsilloliths and Actinomyces: A Multi-institutional Study of Adult Patients Undergoing Tonsillectomy. Otolaryngol Head Neck Surg. 2020. PMID: 32366151. doi:10.1177/0194599820921392
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。